Biodegradable polymers as non-viral carriers for plasmid DNA delivery

Journal of Controlled Release : Official Journal of the Controlled Release Society
Jordy LutenW E Hennink

Abstract

Gene therapy holds a great promise for the treatment of acquired and inherited diseases with a genetic origin that are currently incurable. Non-viral gene delivery systems are gaining recognition as an alternative to viral gene vectors for their potential in avoiding immunogenicity and toxicity problems inherently associated with the use of viral systems. Many cationic polymers have been studied both in vitro and in vivo for gene delivery purposes. However, in recent years there has been a focus on biodegradable carrier systems. The potential advantage of biodegradable carriers as compared to their non-degradable counterparts is their reduced toxicity and the avoidance of accumulation of the polymer in the cells after repeated administration. Also, the degradation of the polymer can be used as a tool to release the plasmid DNA into the cytosol. In this article the recent results obtained with two classes of degradable gene delivery systems, namely those based on water-soluble cationic polymers and on micro- and nanoparticles will be summarized and discussed.

References

Oct 1, 1992·The Journal of Experimental Medicine·R E DonahueR Moen
Aug 1, 1995·Proceedings of the National Academy of Sciences of the United States of America·O BoussifJ P Behr
Oct 1, 1996·Nature Medicine·C CondonL D Falo
Dec 24, 1998·Journal of Controlled Release : Official Journal of the Controlled Release Society·D WangJ Samuel
Jul 30, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·W T GodbeyA G Mikos
Sep 9, 1999·Journal of Controlled Release : Official Journal of the Controlled Release Society·E WalterH P Merkle
Jan 14, 2000·Nature Biotechnology·G ZhuS P Schwendeman
Jan 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·M SinghD O'Hagan
Apr 1, 2000·Journal of Controlled Release : Official Journal of the Controlled Release Society·A M Tinsley-BownG H Farrar
Jun 6, 2000·Advanced Drug Delivery Reviews·E WagnerW Zauner
Feb 22, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·H Q MaoK W Leong
Jul 14, 2001·Journal of Controlled Release : Official Journal of the Controlled Release Society·C PerezM J Alonso
Sep 20, 2001·Journal of the American Chemical Society·J WangK W Leong
Oct 18, 2001·International Journal of Pharmaceutics·M D BrownI F Uchegbu
Nov 16, 2001·Molecular Therapy : the Journal of the American Society of Gene Therapy·C M VargaD A Lauffenburger
Apr 12, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Cheol-Hee AhnSung Wan Kim
Jul 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Ji Hoon Jeong, Tae Gwan Park
Sep 3, 2002·Advanced Drug Delivery Reviews·Thomas MerdanThomas Kissel
Sep 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Wen Guang Liu, Kang De Yao
Sep 11, 2002·Journal of Controlled Release : Official Journal of the Controlled Release Society·Jun WangKam W Leong
Oct 18, 2002·Advanced Drug Delivery Reviews·Jorge HellerRobert Gurny
Mar 12, 2003·Advanced Drug Delivery Reviews·Jayanth Panyam, Vinod Labhasetwar
Mar 20, 2003·Bioconjugate Chemistry·Susan Park, Kevin E Healy
Apr 22, 2003·Proceedings of the National Academy of Sciences of the United States of America·Niren MurthyJean M J Fréchet
May 2, 2003·Journal of the American Chemical Society·Akin AkincRobert Langer
May 10, 2003·Journal of Controlled Release : Official Journal of the Controlled Release Society·J LutenW E Hennink
May 21, 2003·Gene Therapy·Q Liu, D A Muruve
Aug 29, 2003·Expert Opinion on Biological Therapy·Mary Lynne Hedley
Sep 18, 2003·Bioconjugate Chemistry·M Laird ForrestDaniel W Pack
Oct 3, 2003·International Journal of Pharmaceutics·Jun WangKam W Leong
Oct 8, 2003·Current Pharmaceutical Biotechnology·B Ríhová, K Kubácková
Oct 11, 2003·Biotechnology Advances·Sally McTaggart, Mohamed Al-Rubeai

❮ Previous
Next ❯

Citations

May 2, 2013·International Journal of Pharmaceutics·Jong Yuh CherngWim E Hennink
Aug 6, 2013·International Journal of Pharmaceutics·J A CallesE M Vallés
May 4, 2010·Bioconjugate Chemistry·Xiao-Xiang ZhangMark W Grinstaff
Aug 13, 2011·Langmuir : the ACS Journal of Surfaces and Colloids·Tatiana V BurovaAlexei R Khokhlov
Aug 18, 2010·Chemical Communications : Chem Comm·Dongyun ChenYonggang Li
Jun 19, 2008·Nucleic Acids Research·Rudy JulianoHyumin Kang
Mar 15, 2012·Journal of Periodontology·Satheesh ElangovanMansoor Amiji
Oct 9, 2013·International Journal of Nanomedicine·Chuanwei WangYuguang Liu
Aug 23, 2011·Therapeutic Delivery·Viral TamboliAshim K Mitrat
Jan 1, 2014·Acta Biomaterialia·Alberto PurwadaAnkur Singh
Jul 27, 2012·Therapeutic Delivery·Pedro Gomes SanchesOliver C Steinbach
Jun 2, 2014·Colloids and Surfaces. B, Biointerfaces·Kim Cuc Thi NguyenKyung A Cho
Apr 1, 2014·European Journal of Medicinal Chemistry·Miao-Miao XunXiao-Qi Yu
Feb 23, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Martin PiestJohan F J Engbersen
Apr 16, 2013·Journal of Controlled Release : Official Journal of the Controlled Release Society·Luís NovoWim E Hennink
Sep 15, 2014·Protein Expression and Purification·Yu-Jiao YangXian-Zhu Xia
May 11, 2011·World Journal of Surgery·John NemunaitisF Charles Brunicardi
Oct 1, 2013·Drug Delivery and Translational Research·Susan Muthe Alex, Chandra P Sharma
Jun 30, 2009·Inhalation Toxicology·Michael BurClaus-Michael Lehr
Nov 4, 2015·Vaccines·Liam PowlesMagdalena Plebanski
Apr 23, 2009·Expert Opinion on Drug Delivery·Chao Lin, Johan F J Engbersen
Mar 6, 2010·Expert Opinion on Drug Delivery·Ron B ShmueliJordan J Green
Nov 27, 2014·Expert Opinion on Drug Delivery·Luís NovoWim E Hennink
Oct 10, 2009·Journal of Drug Targeting·Joost H van den BergWim E Hennink
Sep 26, 2009·Journal of Pharmaceutical Sciences·G Della PortaE Reverchon
Sep 11, 2014·Journal of Controlled Release : Official Journal of the Controlled Release Society·Luís NovoWim E Hennink
Dec 3, 2014·Advanced Drug Delivery Reviews·S B G BlanquerA A Poot

❮ Previous
Next ❯

Related Concepts

Related Feeds

CREs: Gene & Cell Therapy

Gene and cell therapy advances have shown promising outcomes for several diseases. The role of cis-regulatory elements (CREs) is crucial in the design of gene therapy vectors. Here is the latest research on CREs in gene and cell therapy.

Related Papers

Proceedings of the National Academy of Sciences of the United States of America
O BoussifJ P Behr
Chemical Reviews
Meredith A Mintzer, Eric E Simanek
Nature Reviews. Drug Discovery
D W PackPatrick S Stayton
Advanced Drug Delivery Reviews
Tae Gwan ParkSung Wan Kim
© 2021 Meta ULC. All rights reserved